Business
Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
About this update from Dicot Pharma Ab
Dicot Pharma AB OMXSTO:DICOT:RECEIVES FDA CLEARANCE TO INITIATE THE FIRST PART OF THE PHASE 2B STUDY WITH LIB-01 IN THE U.S.APPLICATION TO COMMENCE STUDY IN EUROPE WILL BE SUBMITTED TO RELEVANT REGULATORY AUTHORITIES IN Q3STUDY IS EXPECTED TO START IN SECOND HALF OF 2026, IN LINE WITH PREVIOUSLY COMMUNICATED TIMELINE